The treatment of Barrett’s esophagus
نویسندگان
چکیده
The reflux of the gastric juice in the esophagus can determine the injury of the esophageal epithelium. When the healing of the lesion is done by replacing the normal squamous epithelium with columnar epithelium, the entity is called Barrett's esophagus (BE). Although controversial, some studies showed 0,5% per year the incidence of the esophageal adenocarcinoma in patients with BE, 30 times more often than general population. Taking into consideration the possible development of an adenocarcinoma, the patients with Barrett's esophagus require endoscopic surveillance after a standardized protocol. There is still much controversy about the treatment of patients with Barrett's esophagus, especially in the presence of dysplasia. The aims of the treatment are gastro-esophageal reflux symptoms control, healing of associated esophagitis and prevention of development of adenocarcinoma.
منابع مشابه
Barrett’s Esophagus - American Family Physician
managed in the primary care setting. Surveys suggest that approximately 20 percent of U.S. adults have symptoms of GERD at least once a week.4 A subgroup of patients with GERD develop severe complications that include erosive esophagitis, stricture formation, Barrett’s esophagus, and adenocarcinoma of the esophagus. Because Barrett’s esophagus is thought to be associated with the development of...
متن کاملBARRETT’S ESOPHAGUS AND ASSOCIATED ADENOCARCINOMA - Studies on pathogenesis, clinical staging, and cost-utility of cancer treatment
.................................................................................................................... 8 INTRODUCTION ......................................................................................................... 10 REVIEW OF THE LITERATURE ................................................................................. 12 1. Barrett’s esophagus ..........................
متن کاملProposed Use of Deoxycholic Acid (DCA) and Ursodeoxycholic Acid (UDCA) in a Treatment Regimen for Barrett’s Esophagus
Citation: Stamp D. (2016). Proposed Use of Deoxycholic Acid (DCA) and Ursodeoxycholic Acid (UDCA) in a Treatment Regimen for Barrett’s Esophagus. M J Canc. 1(2): 007. INTRODUCTION Huo et al [1] first placed 250 uM of the hydrophobic bile acid (DCA) into the esophagus of patients with Barrett’s esophagus (BE) and left it there for 5 min. The DCA was dissolved in alcohol. Subsequent examination o...
متن کاملBarrett’s esophagus: an exaggerated risk?
Over the last decade, the therapy of early Barrett’s neoplasia has significantly changed by the introduction of endoluminal therapy. Nowadays, endoscopic resection of mucosal cancer in combination with radiofrequency ablation of the remaining Barrett’s epithelium, has replaced surgery as a first choice treatment for this condition. In view of this changed treatment paradigm, it has become even ...
متن کاملThe future of endoscopic treatment of early Barrett neoplasia: the endoscopist's view.
The field of Barrett’s esophagus ablation has come a long way since the original pioneering work of Brandt and Berenson in the early 1990s [1, 2]. In fact, ablation is now viewed as a legiti− mate first−line treatment option for healthy pa− tients with high grade dysplasia and early adeno− carcinoma, based on studies performed to date. Furthermore, the notion of complete ablation of Barrett’s e...
متن کاملThe Prevalence of Barrett’s Esophagus in Outpatients with Dyspepsia in Shaheed Beheshti Hospital of Kashan
Gastroesophageal reflux disease (GERD) is the main known etiological factor for Barrett’s esophagus (BE), and BE is the precursor lesion of esophageal adenocarcinoma. The prevalence of BE is reported mostly from gastroenterology centers and there are only a few reported cases from outpatients with dyspepsia. A large number of patients with GERD have degrees of dyspepsia. This study primarily ai...
متن کامل